Ottawa Commits $5M to Expand Canadian HIV Self-Testing and Support

Funding Allocation and Distribution Strategy

According to federal announcements, the $5 million financial commitment is split into two distinct operational envelopes: $2 million dedicated directly to purchasing and dispatching test kits, and $3 million allocated to support the hiring of peer-based support workers through community-led organizations, as reported by The Canadian Press. Manitoba Liberal MP Doug Eyolfson noted that these resources are designed to ensure that geographic location or personal circumstances do not dictate an individual’s access to vital medical care.

Addressing Undiagnosed HIV Cases in Canada

Public Health Agency of Canada surveillance data shows that 2,288 new HIV diagnoses were reported nationally in 2024, equating to a rate of 5.5 per 100,000 people. Federal health estimates indicate that roughly 7,000 people living with HIV across the country remain unaware of their status. Dr. Joss Reimer emphasized that knowing one’s HIV status serves as the critical initial step toward securing effective treatment. According to federal health officials, individuals who receive effective treatment can achieve and maintain an undetectable viral load, which completely prevents sexual transmission of the virus.

Regional Disparities and Provincial Impact

Infection rates vary widely across provinces, with surveillance figures showing Saskatchewan recorded a rate of 18.6 new diagnoses per 100,000 people in 2024, compared with 19.5 in Manitoba, 4.3 in Alberta, and 3.0 in British Columbia, according to federal data. Manitoba declared a public health emergency in May due to soaring transmission rates estimated to be three times higher than the national average. Manitoba Health Minister Uzoma Asagwara welcomed the federal injection as a significant step forward, noting that the province detected 328 new cases last year compared with just 90 in 2019.

Community Advocacy and Testing Methods

Advocacy groups have underscored the vital role of community organizations in reaching vulnerable populations, including First Nations, Inuit, and Métis people, gay and bisexual men, transgender individuals, people who share drug-use equipment, and racialized communities. Shohan Illsley, executive director of the Manitoba Harm Reduction Network, stated that placing testing tools directly into the hands of trusted local organizations reduces stigma and fosters dignified care. Currently, Canada has approved two self-testing devices: the OraQuick test, which uses an oral swab, and the INSTI test, which requires a finger prick.

Frequently Asked Questions